Reduced cGMP levels in CSF of AD patients correlate with severity of dementia and current depression

BACKGROUND: Alzheimer’s disease (AD) is a neurodegenerative disorder, primarily affecting memory. That disorder is thought to be a consequence of neuronal network disturbances and synapse loss. Decline in cognitive function is associated with a high burden of neuropsychiatric symptoms (NPSs) such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Hesse, Raphael, Lausser, Ludwig, Gummert, Pauline, Schmid, Florian, Wahler, Anke, Schnack, Cathrin, Kroker, Katja S., Otto, Markus, Tumani, Hayrettin, Kestler, Hans A., Rosenbrock, Holger, von Arnim, Christine A. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343324/
https://www.ncbi.nlm.nih.gov/pubmed/28274265
http://dx.doi.org/10.1186/s13195-017-0245-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343324/
https://www.ncbi.nlm.nih.gov/pubmed/28274265
http://dx.doi.org/10.1186/s13195-017-0245-y

Ejemplares similares